We are very pleased: the renowned trade magazine Laborjournal has devoted a detailed article to our Greifswald start-up, presenting our approach to fully synthetic nano-antibodies. For us, this visibility in one of the most important industry media in the life sciences is a welcome confirmation of our work.
Antibodies are part of the basic equipment of practically every molecular biology laboratory, from diagnostics to drug development. Until now, however, they have mostly been obtained from animal sources. This is not only ethically questionable, but also time-consuming and costly, and the quality varies considerably from animal to animal. In the end, a large proportion of the antibodies produced this way cannot be used meaningfully at all.
This is exactly where Ymolution comes in. We produce nano-antibodies fully synthetically and without animal testing. At the heart of our process is a spore display: because bacterial spores are extremely robust against almost all external influences, very stringent screening conditions can be applied without jeopardizing the crucial link between genotype and phenotype. This narrows the pool of promising candidates from the usual several hundred down to only about ten to fifteen. Another advantage: because the antibodies do not have to be transported across the cell membrane in this process, even difficult candidates, for example strongly charged or hydrophobic ones, can be displayed reliably.
The result is a considerably faster and more precise route to the right antibody: what classically takes four to six months is achieved with our approach in about two weeks. Our particularly small nano-antibodies of around 15 kilodaltons open up applications that remain closed to classical, much larger antibodies.
You can read the full article directly at Laborjournal: https://www.laborjournal.de/editorials/3421.php
Are you interested in working with us or would you like to learn more about our technology “made in Greifswald”? Get in touch.
The Ymolution team